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Annexin 11 is a widely expressed calcium- and phos-
pholipid-binding protein that resides in the nucleo-
plasm in many cultured cell lines. This is in contrast to
its most extensively characterized in vitro ligand, the
small calcium-binding protein S100A6 (calcyclin), which
is concentrated in the nuclear envelope. Here we have
examined the significance of the association of annexin
11 and S100A6 by asking whether circumstances exist in
which the two proteins occupy the same subcellular
localization. First, we show that in both A431 and vas-
cular smooth muscle cells, elevation of intracellular
Ca2 leads to translocation of annexin 11 from the nu-
cleus to the nuclear envelope where it co-localizes with
S100A6. We also demonstrate, using fusions of annexin
11 with green fluorescent protein, that whereas the C-
terminal core domain of annexin 11 is essential for Ca2
sensitivity, the N-terminal domain is required for tar-
geting to the nuclear envelope. Second, we show that
annexin 11 relocalizes to the nuclear envelope as A431
cells transit from early to mid-prophase. In late
prophase, at the time of nuclear envelope breakdown,
annexin 11 and S100A6 become intensely localized with
lamina-associated polypeptide 2 to folds in the nuclear
envelope. From metaphase to telophase S100A6 is de-
graded, but in late telophase annexin 11 associates with
the reforming nuclear envelope before resuming a nu-
cleoplasmic location in interphase. These results show
that co-localization of annexin 11 and S100A6 at the
nuclear envelope may be regulated either by elevation
of intracellular Ca2 or by cell cycle progression and
provide the first evidence that these proteins may asso-
ciate in vivo.
The vertebrate annexins constitute a family of 12 distinct
genes that encode proteins with the shared ability to bind
calcium dependently to negatively charged phospholipids (for
reviews see Refs. 1 and 2). Despite their considerable struc-
tural similarity and overlapping biophysical characteristics,
research in recent years indicates that individual annexins
have distinct physiological roles. Thus, although annexin func-
tion is still not understood at the mechanistic level, targeted
gene disruption experiments in mice and chick DT40 cells have
revealed a range of phenotypes that are generally unaccompa-
nied by compensatory changes in expression of other annexins.
These phenotypes point to roles for annexins in diverse biolog-
ical processes, including vesicle trafficking (3, 4), calcium sig-
naling (5, 6), and lipid raft organization (7, 8).
For several annexins it is clear they do not act alone. An-
nexin 2 was first isolated as a component of a stable heterotet-
rameric complex with S100A10 (formerly p11) (9). S100 pro-
teins form a branch of the EF-hand Ca2-binding proteins
exemplified by calmodulin and constitute a second family of
calcium-binding proteins of poorly understood functions (10).
The (annexin 2S100A10)2 complex is unusual in being calcium-
independent. This is because the two EF-hands of S100A10
contain amino acid changes that render the canonical helix-
loop-helix incapable of binding calcium ions while driving
structural changes that effectively lock S100A10 into a form
that mimics a hypothetical Ca2-bound structure (11). Al-
though the complex is stable in the absence of Ca2, the two
annexin 2 monomers within the complex retain Ca2 sensitiv-
ity, rendering the quaternary protein complex potentially sen-
sitive to changes in intracellular Ca2 concentration.
Interactions between annexins and S100 proteins are now
known to extend to other members of these protein families.
Annexin 1 binds to S100A11 (formerly S100C) (12, 13) and
annexin 11 binds to S100A6 (formerly calcyclin) (14). In con-
trast to the annexin 2S100A10 complex, interactions between
annexins 1 and 11 and their respective S100 ligands are abso-
lutely dependent on Ca2. For this reason, it has so far proven
impossible to isolate the Ca2-dependent annexinS100 com-
plexes from cell or tissue extracts. The discovery that annexin
11 binds to S100A6 was the result of affinity chromatography
using immobilized S100A6 (15). A reverse strategy, in which
the immobilized N terminus of annexin 1 was used as bait in
A431 cell extracts, led to the discovery of S100A11 as a cognate
binding partner (12). Given the specificity of the annexin
1-S100A11 and annexin 11-S100A6 interactions and the rela-
tively low Ca2 requirement for their formation, it is reasona-
ble to expect that under certain circumstances these complexes
may exist in living cells. Indeed, mutation of the binding site
for annexin 1 on S100A11 results in failure of S100A11 to be
recruited to transferrin receptor-positive endosomes, indicat-
ing that this interaction does indeed occur in vivo (16).
Despite several studies on the interaction between annexin
11 and S100A6, including identification of the binding site to
residues 49–62 in the long N-terminal domain (17), the mutual
exclusion of the two proteins from a single subcellular compart-
ment raises the possibility that the annexin 11S100A6 com-
plex may exist only in vitro. Because annexin 11 and S100A6
are both Ca2-binding proteins and because S100A6 protein
levels oscillate in a cell cycle-dependent manner (18), we there-
fore examined whether Ca2 fluxes and/or cell cycle progres-
sion might regulate the co-localization of annexin 11 and
S100A6. We show here that, whereas S100A6 is relatively
sedentary in the nuclear envelope, annexin 11 interacts dy-
namically with the nuclear envelope in both a Ca2- and cell
cycle-dependent manner. These results support the idea of a
functional relationship between annexin 11 and S100A6.
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Cell Culture Conditions—A431 cells were grown in Dulbecco’s mod-
ified Eagle’s medium (Invitrogen) supplemented with 10% (v/v) fetal
calf serum, 100 units/ml penicillin, 100 g/ml streptomycin, and 292
g/ml L-glutamine at 37 °C in 5% CO2-humidified incubators. Cells
were kept subconfluent, and the medium was changed every 2 to 3 days.
Pig vascular smooth muscle cells (VSMC),1 generously provided by Dr.
Y. Hong (University College London, UK), were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 20% (v/v) fetal calf serum,
100 units/ml penicillin, 100 g/ml streptomycin, and 292 g/ml L-
glutamine. For live cell microscopy, cells were grown in 35-mm glass
bottom microwell dishes (MatTek).
Antibodies and Growth Factors—Primary antibodies for immunoflu-
orescence were L-19 goat polyclonal anti-human annexin 11 (Santa
Cruz Biotechnology), mouse monoclonal anti-pig S100A6 (Sigma), M-20
goat polyclonal anti-mouse lamin B (Santa Cruz Biotechnology), and
mouse monoclonal anti-rat lamina-associated polypeptide 2 (LAP2)
(Transduction Laboratories). Secondary antibodies were donkey anti-
goat-Alexa Fluor 488 (Molecular Probes), donkey anti-mouse-Cy5, and
donkey anti-mouse-TRITC (gift from Dr. C. Futter, Institute of Opthal-
mology, University College London, UK). Antibodies for Western blot-
ting were affinity-purified sheep polyclonal anti-chicken annexin 11
(raised against recombinant chicken annexin 11 protein) and 4G10
mouse monoclonal anti-phosphotyrosine (Upstate Biotechnology). Epi-
dermal growth factor (EGF), a gift from Dr. A. Limb (University College
London, UK), was used at 40 ng/ml, and platelet-derived growth factor
BB (PDGF-BB), a gift from Dr. M. Bailly (University College London,
UK), was used at 50 ng/ml.
Immunofluorescence Microscopy—Cells were washed in PBS, fixed/
permeabilized on ice for 30 min in 2% paraformaldehyde  0.1% Triton
X-100, washed four times in PBS and blocked for 15 min with 1% BSA
(Sigma). Fixed cells were then incubated in a moist chamber with
primary antibody in 1% BSA for 1 h, followed by four washes of 5–10
min each in PBS before incubation with the secondary antibody in 1%
BSA for another hour. After four more washes in PBS, samples were
observed under a Bio-Rad Radiance 2000 AGR 3 (Q) confocal attached
to a Zeiss Axiovert S100TV inverted microscope using a 100 oil im-
mersion lens. Images were acquired with LaserSharp 2000 (Bio-Rad)
and processed using Metamorph 4.6r9 (Universal Imaging).
Immunoprecipitation, SDS-PAGE, and Western Blotting—A431 cell
monolayers were washed in PBS, solubilized in 500 l of lysis buffer (50
mM Tris-HCl, pH 7.4, 50 mM NaCl, 30 mM sodium pyrophosphate, 50
mM sodium fluoride, 100 M sodium orthovanadate, 0.2 mM CaCl2, 1%
Triton X-100, 0.1% BSA, 0.02% sodium azide) supplemented with 10 l
of protease inhibitor mixture (Sigma) per 107 cells and lysed by three
rounds of sonication on ice. Lysates were precleared at 16,000 g for 30
min at 4 °C, followed by incubation with 30 l of 50% Protein G-
Sepharose 4 fast flow slurry (Amersham Biosciences) for 30 min, and
then 5 min of centrifugation at 16,000 g at 4 °C. L-19 goat anti-human
annexin 11 antibody (Santa Cruz Biotechnology) was immobilized on
Protein G-Sepharose beads and added to the precleared lysates for 2 h
at 4 °C and centrifuged, and the supernatant discarded. Beads were
washed four times in lysis buffer minus BSA and once in ice-cold PBS.
After removal of the supernatant, immunoprecipitates were resus-
pended in SDS-PAGE sample buffer, boiled for 5 min, and resolved by
SDS-polyacrylamide gel electrophoresis on discontinuous mini-gels.
Proteins were electroblotted for 45 min at 400 mA onto Hybond-P
polyvinylidene difluoride transfer membrane (Amersham Biosciences).
Membranes were treated with blocking solution (10% skimmed milk
or 10% BSA in PBS-Tween (PBS 0.05% Tween 20)) for 40 min at room
temperature and incubated for 16 h at 4 °C with primary antibody in
PBS-Tween. Following three PBS-Tween washes, membranes were in-
cubated with secondary antibody for 90 min, also in PBS-Tween (1/
10,000 dilution). IgG-horseradish peroxidase conjugates were used as
secondary antibodies. Blots were developed after three more PBS-
Tween washes using the ECL Plus Western blotting detection system
(Amersham Biosciences) and visualized in a Fujifilm Intelligent Dark
Box II coupled to a LAS-1000 charge coupled device-camera.
Generation of Annexin 11Green Fluorescent Protein (GFP) Fusion
Constructs—Full-length human annexin 11 coding sequence, annexin
11 N-terminal domain (nucleotides 1–642 in the annexin 11 coding
sequence), and annexin 11 C-terminal core domain (nucleotides 624–
1515 in the annexin 11 coding sequence) were amplified by RT-PCR
from A431 cDNA and cloned in-frame into pEGFP-C3 vector (Clontech)
for fusion at the C-terminal end of GFP or into pEGFP-N3 vector
(Clontech) for fusion at the N-terminal end of GFP.
Transient Transfection and Live Cell Imaging—Cells were trans-
fected with the different annexin 11GFP fusion constructs using
LipofectAMINE 2000 reagent (Invitrogen) following the manufacturer’s
instructions and incubated for 24 h to allow gene expression before
placing them in a 37 °C preheated microscope chamber with 5% CO2
supply. Cells were observed before and after stimulation under a Bio-
Rad Radiance 2000 AGR-3 (Q) confocal attached to a Zeiss Axiovert
S100TV inverted microscope using a 100 oil immersion lens. Images
were acquired with LaserSharp 2000 (Bio-Rad) and analyzed using
Metamorph 4.6r9 (Universal Imaging).
Cell Synchronization—Cells were grown to 50% confluence and in-
cubated overnight in medium containing 4 mM thymidine (Sigma) to
achieve S phase block. Dishes were extensively washed in PBS and
cultured for a further 6 h in medium containing 0.07 g/ml nocodazole
(Sigma) for growth arrest at the onset of mitosis. Cells were then
extensively washed and allowed to recover in normal medium for 5–60
min before immunofluorescence analysis.
RESULTS
We first examined the subcellular localization of annexin 11
and S100A6 in fixed A431 epidermoid carcinoma cells. Annexin
11 was predominantly nuclear, though excluded from the nu-
cleoli, and was also apparent in punctate form in the cell
cytoplasm (Fig. 1A). In contrast, S100A6 displayed a strong
signal in the region of the nuclear envelope, together with
discrete inner nuclear structures and punctate cytoplasmic
staining that did not coincide with annexin 11. Thus, in un-
stimulated A431 cells, S100A6 and annexin 11 appear to oc-
cupy non-overlapping subcellular compartments. Similar re-
sults were obtained in HeLa and HEp2 cells (data not shown).
To confirm that the S100A6-positive ring-like structure at the
1 The abbreviations used are: VSMC, vascular smooth muscle cells;
LAP2, lamina-associated polypeptide 2; TRITC, tetramethylrhodamine
isothiocyanate; EGF, epidermal growth factor; PDGF-BB, platelet-de-
rived growth factor BB; PBS, phosphate-buffered saline; BSA, bovine
serum albumin; GFP, green fluorescent protein; ALG-2, apoptosis-
linked gene 2.
FIG. 1. Annexin 11 and S100A6 re-
side in distinct subcellular compart-
ments in unstimulated A431 cells. A,
untreated A431 cells were fixed and
stained for annexin 11, S100A6, and DNA
(with propidium iodide). Annexin 11 con-
centrates at the cell nucleoplasm and is
excluded from the nucleoli and the nu-
clear envelope, whereas the fluorescent
signal for S100A6 concentrates mainly at
the nuclear envelope. B, untreated A431
cells were fixed and stained for S100A6,
the inner nuclear envelope protein lamin
B, and DNA. S100A6 strongly co-localizes
with lamin B at the nuclear envelope of
A431 cells.
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nuclear periphery is the nuclear envelope, A431 cells were
co-stained for lamin B, a well characterized resident of the
inner nuclear membrane (Fig. 1B). The results show that
S100A6 is indeed strongly enriched at the nuclear envelope and
also co-localizes with lamin B at focal points within the nu-
cleus. The constitutive association of S100A6 with the nuclear
envelope in A431 cells contrasts with previous studies in vas-
cular smooth muscle cells in which this interaction was re-
ported to be Ca2-dependent (19).
To investigate the Ca2 sensitivity of S100A6 and annexin
11 in our experimental model, A431 cells were exposed to
ionomycin for 30 min prior to fixation and immunostaining
(Fig. 2A). Elevation of intracellular Ca2 caused the relocaliza-
tion of annexin 11 to the nuclear envelope but had little effect
on either S100A6 or the punctate cytoplasmic pool of annexin
11. Because annexin 11 has been reported to be a substrate for
cellular protein kinases, including the calcium-activated tyro-
sine kinase Pyk2 (20, 21), we also examined whether the re-
sponse to ionomycin was accompanied by protein phosphoryl-
ation (Fig. 2B). Immunoprecipitation of annexin 11 from
ionomycin-treated cells, followed by Western blotting with an
anti-phosphotyrosine antibody, revealed that annexin 11 is
indeed phosphorylated on tyrosine under these conditions. In
contrast, neither staurosporine nor EGF treatment led to tyro-
sine phosphorylation of annexin 11, nor did either stimulus
drive the association of annexin 11 to the nuclear envelope (not
shown).
Because the lysis conditions used in these immunoprecipita-
tion experiments favored a whole cell extraction, we next in-
vestigated the ionomycin-induced tyrosine phosphorylation of
annexin 11 in cytosolic and nuclear extracts prepared in the
absence and presence of 200 M Ca2 (Fig. 2C). These experi-
ments demonstrate that preservation of tyrosine phosphoryla-
tion in lysates of ionomycin-treated A431 cells requires the
presence of Ca2 in the lysis buffer. Interestingly, separation of
the nuclear and cytosolic pools led to the apparent partial
degradation of tyrosine-phosphorylated annexin 11 in both
fractions to polypeptide species of 30 and 40 kDa, respectively.
However, reprobing the blot with antisera to annexin 11 shows
that the majority of the protein remains in the 55-kDa form,
suggesting that tyrosine phosphorylation of annexin 11 may
increase its susceptibility to proteolysis.
Because studies elsewhere have shown that annexin 11 can
also be tyrosine-phosphorylated in activated VSMCs (21), we
next examined whether the results obtained in A431 cells
would be paralleled in VSMCs. In these experiments we per-
formed live cell-image analysis to track the localization of an
ectopically expressed annexin 11GFP fusion protein in pri-
mary cultures of porcine VSMCs. A series of confocal images
were obtained every 5 s for 3 min following exposure to iono-
mycin and clearly showed that annexin 11GFP becomes tightly
localized to the nuclear envelope as well as to both plasma
membrane and dispersed intracellular structures within a few
seconds of ionophore treatment (Fig. 3A). Treatment of VSMCs
with PDGF-BB had no effect on the nuclear annexin 11GFP
but led to a concentration of cytoplasmic annexin 11GFP partly
to the plasma membrane and also to intracellular structures
(Fig. 3B). The contrasting effects of ionophore and growth fac-
tor in VSMCs closely match the results obtained in A431 cells.
Consistent with these findings, we observed a negligible effect
of PDGF-BB on tyrosine phosphorylation of annexin 11 in
stimulated VSMCs (Fig. 3C), whereas annexin 11 was clearly
tyrosine-phosphorylated in ionomycin-treated cells.
Next, we investigated the structural basis for the annexin 11
response to ionomycin (Fig. 4). Two constructs were generated
in which the full-length annexin 11 coding sequence was fused
to GFP, one with GFP at the C terminus of annexin 11
(anx11GFP) and the other with GFP at the N terminus
(GFPanx11). Two additional expression plasmids were con-
structed, one in which the four-repeat Ca2-binding C termi-
nus of annexin 11 was replaced with GFP (N-terGFP) and a
second in which GFP replaced the long proline-, tyrosine- and
glycine-rich N terminus (GFPC-ter). Transient transfection of
these constructs in A431 cells revealed that anx11GFP and
GFPanx11 were expressed in both the nucleus and cytoplasm
of living cells, with anx11GFP tending to exhibit a greater
enrichment in the nucleus. N-terGFP expression was mark-
edly stronger in the nucleus than the cytoplasm, whereas
GFPC-ter was completely excluded from the nucleus. This is in
agreement with previous observations that showed the N-ter-
FIG. 2. Annexin 11 relocates to the
nuclear envelope in response to ele-
vation of intracellular Ca2 levels. A,
A431 cells were stimulated for 30 min
with 2.5 M ionomycin in medium con-
taining Ca2 and subsequently fixed and
stained for annexin 11 and S100A6. An-
nexin 11 partially relocates to the nuclear
envelope under these conditions (green
arrows), where it co-localizes with
S100A6 (left panels). B, A431 cells were
either stimulated with 2.5 M ionomycin
for 30 min, 1 M staurosporine for 3 h, 40
ng/ml EGF for 15 min, or left untreated
(control). Immune complexes were re-
solved by SDS-PAGE followed by Western
blotting with an anti-phosphotyrosine an-
tibody, and for annexin 11 to confirm
equal loadings. C, A431 cells were ex-
posed to ionomycin or buffer alone and
extracted into lysis buffer containing ei-
ther 200 M CaCl2 or 5 mM EGTA. Sam-
ples were centrifuged, and annexin 11
was subsequently immunoprecipitated
from both supernatant (Cyt) and resolubi-
lized nuclear pellet (Nuc). Following SDS-
PAGE and Western transfer, the mem-
brane was immunoblotted first with an
anti-phosphotyrosine antibody and then,
after stripping the blot, with an antibody
to annexin 11.
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minal domain of annexin 11 is both necessary and sufficient for
the nuclear localization of annexin 11 (22).
We then compared the responses of these expression con-
structs to ionomycin treatment in the presence and absence of
extracellular Ca2. Both anx11GFP and GFPanx11 displayed
almost complete relocalization from the nucleus to the nuclear
envelope, together with a change from diffuse cytoplasmic flu-
orescence to punctate cytoplasmic or plasma membrane-asso-
FIG. 3. Calcium-dependent relocalization of annexin 11 in vascular smooth muscle cells. A, porcine VSMCs were transiently trans-
fected with annexin 11-GFP and then stimulated with 2.5 M ionomycin while being imaged every 5 s on the heated stage of a confocal microscope.
Selected images from the timed series are shown, revealing a rapid and striking translocation of annexin 11 to the nuclear envelope and various
other intracellular membranes. B, VSMCs were transiently transfected with annexin 11GFP and imaged as in panel A before and after the
addition of 50 ng/ml PDGF-BB. The images show PDGF-dependent relocalization of cytosolic annexin 11GFP to the plasma membrane and
cytoplasmic vesicles. C, VSMCs were exposed to either 2.5 M ionomycin or 50 ng/ml PDGF for 15 min or left untreated (control), and annexin 11
was immunoprecipitated from total cell extracts. Following SDS-PAGE and Western transfer, the blot was probed first with an antibody to
phosphotyrosine and, after stripping, to an antibody to annexin 11 to confirm equal protein loadings.
FIG. 4. Live cell imaging of annexin 11GFP fusions in A431 cells. A431 cells were transiently transfected with full-length human annexin
11 coding sequence fused to GFP either at the C terminus (anx11GFP) or at the N terminus (GFPanx11), with the annexin 11 proline-, tyrosine-,
and glycine-rich (PYG) N-terminal domain fused to GFP (N-terGFP), or with the annexin 11 C-terminal core domain fused to GFP (GFPC-ter).
Cells expressing the fusion constructs were imaged before and after the addition of 2.5 M ionomycin, both in Ca2-containing and Ca2-free
external medium. After stimulation with ionomycin, the full-length annexin 11 fusion proteins relocate primarily to the nuclear envelope (pink
arrowheads) and can also be detected with a punctate pattern at the cytoplasm/plasma-membrane, whereas the fusion protein containing the
annexin 11 N-terminal domain does not respond to ionomycin treatment. The annexin 11 C-terminal core domain containing the four conserved
annexin repeats relocates to intracellular membranes but not the nuclear envelope. These changes in localization occur both in the presence and
absence of external Ca2 (pink/yellow arrowheads), suggesting that mobilization of Ca2 from intracellular stores is sufficient to elicit this
response.
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ciated fluorescence. Similar results were obtained regardless of
the presence or absence of extracellular Ca2, indicating that
mobilization of Ca2 from intracellular stores alone is suffi-
cient to elicit these responses. In contrast, N-terGFP com-
pletely failed to respond to ionomycin, and although GFPC-ter
exhibited sensitivity to Ca2 by relocating to intracellular
membranes, there was no evidence of preferential transloca-
tion to the nuclear envelope. These results demonstrate that
whereas the C-terminal core domain of annexin 11 is essential
to confer Ca2 sensitivity, the N-terminal domain determines
the specificity for the nuclear envelope in the Ca2-dependent
relocalization of annexin 11. Furthermore, the images obtained
using anx11GFP and GFPanx11 demonstrate that GFP may
be fused to either end of the annexin 11 molecule without
interfering with normal responses to changes in intracellular
Ca2 concentration.
Although these results reveal a potential mechanism
whereby the annexin 11-S100A6 interaction might be regu-
lated, we were interested to explore the possibility of a cell
cycle-dependent interaction. In A431 cells at early prophase we
obtained evidence in support of this idea (Fig. 5A). At this point
in the cell cycle the nuclear pool of annexin 11 apparently
relocates, at least in part, to the nuclear envelope. The annexin
11 remaining in the nucleus becomes distinct from the con-
densed DNA content, which contrasts with the picture obtained
for interphase cells (Fig. 1A). We also observed, in cells further
into prophase, that annexin 11 becomes associated with invagi-
nations or folds in the nuclear envelope where it co-localizes
with S100A6. The pattern of immunostaining for annexin 11
and S100A6 in these late prophase cells is similar to that
reported for other nuclear envelope proteins, in particular
LAP2 (23). We therefore co-stained late prophase cells for an-
nexin 11 and LAP2 (Fig. 5B), which enabled us to confirm that
annexin 11 is indeed associated with microtubule-induced folds
that serve an initiating role in nuclear envelope breakdown
(24).
S100A6 immunostaining was virtually undetectable in A431
cells from metaphase to telophase (not shown), indicating that
FIG. 5. Dynamic association of an-
nexin 11 with the nuclear envelope
during cell division. A431 cells were
synchronized in mitosis, fixed, and
stained for annexin 11, DNA, and S100A6
(A) or the inner nuclear membrane pro-
tein LAP2 (B) during prophase. Annexin
11 invades the nuclear envelope at dis-
crete foci in early prophase (panel A, pink
arrowheads) and concentrates at folds in
the nuclear envelope where it colocalizes
with S100A6 (panel A, yellow arrow-
heads) and with LAP2 (panel B, pink ar-
rowheads). A431 cells were synchronized
in mitosis, fixed, and stained for annexin
11, DNA, and LAP2. The images show
cells engaged in nuclear envelope reas-
sembly during late telophase and recently
divided cells in early interphase (C). An-
nexin 11 is enriched at the nascent nu-
clear envelope of cells undergoing cytoki-
nesis, together with LAP2 (top row, white
arrowheads), before shuttling back into
the nucleus where it resides during inter-
phase (bottom row).
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S100A6 protein levels drop during mitosis. This observation is
in agreement with previous studies that showed the level of
expression of S100A6 is regulated in a cell cycle-dependent
manner, peaking in the transition from G0- to S-phase in
smooth muscle cells (18). We therefore immunostained A431
cells in telophase for annexin 11 and LAP2 (Fig. 5C). In late
telophase, annexin 11 and LAP2 again co-localize, this time in
the reforming nuclear envelope. However, while LAP2 remains
clearly associated with the nuclear envelope as cells progress
into early interphase, annexin 11 becomes concentrated within
the nucleus. These observations show that annexin 11 displays
a dynamic and biphasic interaction with the nuclear envelope,
first during nuclear envelope breakdown and again during
reassembly of the nuclear envelope.
DISCUSSION
Annexin 11 is unusual within the annexin family in being a
predominantly nuclear protein. This is in contrast to its most
extensively characterized in vitro ligand, S100A6, which is
shown here and in other studies (19) to be localized to the
nuclear envelope. Because the annexin literature contains sev-
eral unverified reports of interactions between annexins and
putative intracellular ligands, it is important to establish
which, if any, of these occur in vivo because such interactions
are likely to have functional consequences. A more recently
identified ligand of annexin 11, namely the penta-EF-hand
protein ALG-2 (apoptosis-linked gene 2) (25) is expressed in the
nucleus (26), though ALG-2 also binds annexin 7, peflin, and
AIP1/Alix (25, 27). The binding site for ALG-2 on annexins 7
and 11 is located in the long PYG domain at the N terminus of
each annexin, a domain that is also present in AIP1/Alix.
Because the binding sites for ALG-2 and S100A6 on annexin 11
are therefore both located in the N terminus, these observa-
tions raise the possibility that, depending on subcellular local-
ization and the availability of free Ca2, S100A6 and ALG-2
may compete for and differentially modulate the properties of
annexin 11. However, prior to consideration of these hypothet-
ical possibilities it is necessary to establish a prerequisite for
the annexin 11-S100A6 interaction, namely that the two pro-
teins occupy a single subcellular compartment.
We show here that whereas annexin 11 and S100A6 are
unlikely to interact in vivo in interphase cells under resting
conditions, they are both present at the nuclear envelope upon
elevation of intracellular calcium. Interestingly, despite the
fact that annexin 11 and S100A6 are both Ca2-binding pro-
teins, annexin 11 alone manifested its Ca2 sensitivity as a
change in localization. Moreover, the N-terminal domain of
annexin 11, known to contain the S100A6-binding site, was
necessary for the relocalization of annexin 11 to the nuclear
envelope in ionomycin-treated A431 cells, reinforcing the idea
that the association of annexin 11 with the nuclear envelope in
the presence of calcium may occur via a direct interaction with
S100A6. The finding that ionomycin treatment leads not only
to the relocalization of annexin 11 to the nuclear envelope but
also to its tyrosine phosphorylation suggests that a Ca2-acti-
vated tyrosine kinase may be involved in the specific associa-
tion of annexin 11 with the nuclear envelope. Thus, in two
distinct cell types we have shown that ionophore-mediated
translocation of annexin 11 to the nuclear envelope is accom-
panied by annexin 11 tyrosine phosphorylation, whereas
growth factor stimulation has no effect on either parameter.
The failure of EGF and PDGF-BB to induce tyrosine phospho-
rylation of annexin 11 is consistent with a previous report in
which it was shown that stimulation of VSMCs with PDGF-BB
induced tyrosine phosphorylation of annexin 11 only when
added in conjunction with peroxovanadate (21). Nevertheless,
these observations raise the question why EGF and PDGF fail
to reproduce the responses observed with ionomycin, given that
both growth factors also mobilize Ca2. The most likely expla-
nation for this apparent discrepancy is that the nucleus is
‘buffered’ from growth factor-mediated changes in cytosolic
Ca2 but not from the effects of ionophore (28, 29).
The role of annexin 11 at the nuclear envelope during nu-
clear envelope breakdown and nuclear envelope reassembly is
not known, but our findings illustrate a physiological situation
in which annexin 11 and S100A6 might interact in vivo. The
enrichment of annexin 11 at the nuclear envelope invagina-
tions created by microtubules during nuclear envelope break-
down (24) is of particular interest because it could indicate a
role for annexin 11 as a link between the nuclear envelope and
the microtubules at these sites. Furthermore, several reports
have established that calcium is required for nuclear envelope
breakdown in eukaryotic cells (30, 31) and that spontaneous
cell cycle-dependent Ca2 transients are generated by pulsatile
fluxes in inositol trisphosphate (32). Calcium is also required
for lamin B degradation (33), indicating a role for Ca2-binding
proteins in these events. As a cell cycle-regulated nuclear Ca2-
binding protein, it is clearly possible that via its interaction
with S100A6 annexin 11 has a role in membrane deconstruc-
tion during nuclear envelope breakdown. In contrast, the reap-
pearance of annexin 11 during nuclear envelope reassembly
may simply reflect passive transit of the protein to its notion-
ally inactive nucleoplasmic location. If the putative annexin
11S100A6 complex possesses such destructive activity, it
would make sense that S100A6 protein levels are almost un-
detectable at the point in the cell cycle of nuclear envelope
reassembly, thereby eliminating any possible and untimely
deconstructive activity of the annexin 11S100A6 complex.
In conclusion, we have demonstrated that elevation of intra-
cellular Ca2 concentration and cell cycle-dependent events are
independently capable of driving the translocation of annexin
11 from the nucleoplasm to the nuclear envelope. Our observa-
tions support the idea that annexin 11 and S100A6 interact in
vivo and provide evidence for a role for annexin 11 in the
regulation of nuclear envelope dynamics.
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